sibutramine has been researched along with Delirium in 1 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández, P | 1 |
| Peiró, AM | 1 |
1 other study available for sibutramine and Delirium
| Article | Year |
|---|---|
A sibutramine-induced delusional disorder relapse.
Topics: Anti-Obesity Agents; Cyclobutanes; Delirium; Humans; Male; Middle Aged; Obesity; Recurrence; Schizop | 2007 |